Common Candidate Genes: Intriguingly, some of these candidate genes are emerging as potential contributors to both conditions
As awareness around metabolic health grows, discussions around GLP-1 are becoming an essential part of these consultations
Nutrition made simple, results made certain
Novo Nordisk, Pfizer and other big pharma companies have just taken [the hormone] GLP-1 itself, and spent 20 years stabilising the peptide, making it druggable, so its not broken down [in the body], explains John Unitt, vice president of immunology and inflammation drug discovery at Sygnature Discovery in Nottinghamshire, UK, and a GPCR drug discovery expert
Prolonged or high-dose use of BPC-157 may carry a theoretical risk of vascular proliferation in undesired tissues, particularly in individuals with cancer or pre-existing vascular disease. Perovic, D